World's First Heart Valve Replacement Using Extended Reality Platform Brings the Operating Room to the Remote Surgical Specialist for Virtual Support During Live Procedures

Platform Significantly Reduces Travel as a Barrier to Patient Care

The Jewish General Hospital (JGH), a member facility of the West-Central Montreal Health Authority (CIUSSS), together with Auger Groupe Conseil Inc. (AGC) and Medtronic Canada ULC ― a subsidiary of Medtronic plc (NYSE:MDT) ― have pioneered the first application of the Microsoft HoloLens for use in real-time, extended reality (XR) clinical support of a minimally invasive heart procedure.

Cardiac surgeon Dr. Felix Ma, and cardiologist Dr. Ali Abualsaud wearing HoloLens on the right. (CNW Group/Medtronic Canada ULC)

On March 15 th , 2021, this novel partnership completed the first end-to-end remotely guided transcatheter aortic valve implant/replacement (TAVI/TAVR) – a minimally invasive procedure to replace a heart valve. Dr. Sam Radhakrishnan, the proctor or teaching specialist in Toronto , was able to remotely guide the JGH TAVI team of Dr. Ali Abualsaud , Dr. Nathan Messas , and Dr. Emmanuel Moss through the procedure in real time at the JGH in Montreal , using the intra-operative extended reality platform. It is comprised of three key elements:

  • The Microsoft HoloLens 2, a headset which enables bidirectional remote viewing in real time. The use of extended reality headsets and glasses has grown during the pandemic because of the limitations on travel to and within a hospital.
  • A modular system that allows the remote proctor to view the cardiac event monitors in real-time, without requiring the active clinician wearing the HoloLens 2 to look up at the screens.
  • A three-dimensional clinical pathway overlay depicting step-by-step instructions for a specific surgical procedure.

"We think of it as bringing the operating room to the surgical specialist. Rather than coordinating resources to bring a specialist to another hospital for training, now we can greatly simplify the process, which can help improve the timeliness of patient care, especially in an emergency," said Dr. Lawrence Rudski , director of the Azrieli Heart Center. "There are significant advantages to using a real-time, extended-reality system for both the proctor and the clinician on the receiving end, such as having the same view – which is almost better than being in the same, often crowded, room. In addition, this platform has the flexibility to be expanded to many other types of procedures."

During the initial peak of the pandemic in spring 2020, the JGH was designated as a lead COVID-19 treatment site. The ensuing staffing challenges, combined with travel restrictions, required effective and remote training solutions. In collaboration with Quebec engineering firm AGC, the JGH piloted the use of the Microsoft HoloLens to help train and redeploy staff.

"We chose to work with Microsoft mainly because of the HoloLens 2's unmatched performance and in part because of the security offered by their encryption design," said Marcel Lafontaine , CEO of AGC. "We are very proud of our work in combining the mixed reality experience of voice, video and a 3D overlay with no lag time. This is a unique plug-and-play solution, and we're very excited to see it deployed in such an impactful way for clinicians, and ultimately for patients."

The initial success of this project led to developing remote support in a complex clinical pathway and connectivity to medical imaging with the help of leading medical device company Medtronic.

"We are thrilled to be able to contribute our expertise to this unique partnership and are looking forward to seeing this collaboration extend to other clinical pathways," said Richard Paré, regional business director of the CardioVascular Portfolio at Medtronic Canada. "This innovative platform can enable health systems to optimize surgical resources and scheduling, while protecting staff, during the pandemic but also afterwards as they shift their focus to addressing the surgical backlog."

The partnership is currently planning additional applications in the field of cardiovascular medicine and in other areas.

This project is supported by OROT Innovation Hub at the JGH.

Microsoft and HoloLens are trademarks of the Microsoft group of companies.

About   CIUSSS West-Central Montreal
The Integrated Health and Social Services University Network for West-Central Montreal (CIUSSS West-Central Montreal) is committed to providing healthcare recipients with timely access to a seamless continuum of care that focuses on individuals' particular needs.

The area covered by this network is home to approximately 345,000 people, who are served by more than 30 member facilities. Included are one of Montreal's leading hospitals (the Jewish General Hospital) and an interlocking array of three specialized hospitals, five CLSCs, two rehabilitation centres, six long-term care sites, two-day centres and several affiliated research facilities.

Treatment and care are provided by a staff of more than 12,000, and over 600 doctors.

About   Auger Groupe Conseil Inc.
https://www.augergroupe.com/en/augmented-reality
Founded in 1985, Auger Groupe Conseil consists of engineers and IT experts with a focus on the industrial and medical sectors. This includes expertise in Microsoft business & development partnerships, mixed reality platforms such as VR / AR / XR, and Artificial Intelligence. AGC is based in Canada , with teams in the USA and Spain .

About Medtronic Canada ULC
Proudly serving Canadian healthcare for over 50 years, Medtronic Canada ULC ( www.medtronic.ca ) is a subsidiary of Medtronic plc, the world's largest medical technology, services, and solutions company — alleviating pain, restoring health, and extending life for millions of people around the world. Serving physicians, hospitals, and patients across the country, Medtronic Canada ULC is headquartered in Brampton, Ontario , with regional offices in Montreal and Vancouver . The company is focused on collaborating with stakeholders around the world to take healthcare Further, Together.

Any forward-looking statements are subject to risks and uncertainties such as those described in Medtronic's periodic reports on file with the U.S. Securities and Exchange Commission. Actual results may differ materially from anticipated results.

Medtronic Canada ULC Logo (CNW Group/Medtronic Canada ULC)

SOURCE Medtronic Canada ULC

Cision View original content to download multimedia: https://www.newswire.ca/en/releases/archive/June2021/21/c2858.html

News Provided by Canada Newswire via QuoteMedia

The Conversation (0)

Bausch Health Responds to Rumors of a Potential Sale of Bausch + Lomb

Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC) (the "Company" or "Bausch Health"), a global, diversified pharmaceutical company enriching lives through a relentless drive to deliver better health outcomes, issued the following statement in response to a request from the Canadian Investment Regulatory Organization (CIRO

"As previously disclosed, the Company believes that completing the full separation of its subsidiary, Bausch + Lomb Corporation (NYSE/TSX: BLCO) ("Bausch + Lomb"), makes strategic sense. The Bausch Health Board of Directors authorized management and management of its subsidiary, Bausch + Lomb, to explore a potential sale, which is one of several options being considered to complete the separation. That process is ongoing. No decision has been reached to proceed with any particular transaction, and there can be no assurance that it will result in a transaction.

News Provided by ACCESSWIRE via QuoteMedia

Keep reading...Show less

Medtronic announces cash dividend for third quarter of fiscal year 2025

The board of directors of Medtronic plc (NYSE: MDT) on Thursday, December 5, 2024, approved the company's cash dividend for the third quarter of fiscal year 2025 of $0 .70 per ordinary share. This quarterly declaration is consistent with the dividend increase announcement made by the company in May 2024. Medtronic is a constituent of the S&P 500 Dividend Aristocrats index, having increased its annual dividend payment for the past 47 consecutive years. The dividend is payable on January 10, 2025 to shareholders of record at the close of business on December 27, 2024 .

About Medtronic
Bold thinking. Bolder actions. We are Medtronic . Medtronic plc , headquartered in Galway , Ireland , is the leading global healthcare technology company that boldly attacks the most challenging health problems facing humanity by searching out and finding solutions. Our Mission — to alleviate pain, restore health, and extend life — unites a global team of 95,000+ passionate people across more than 150 countries. Our technologies and therapies treat 70 health conditions and include cardiac devices, surgical robotics, insulin pumps, surgical tools, patient monitoring systems, and more. Powered by our diverse knowledge, insatiable curiosity, and desire to help all those who need it, we deliver innovative technologies that transform the lives of two people every second, every hour, every day. Expect more from us as we empower insight-driven care, experiences that put people first, and better outcomes for our world. In everything we do, we are engineering the extraordinary. For more information on Medtronic , visit www.Medtronic.com and follow Medtronic on LinkedIn .

News Provided by PR Newswire via QuoteMedia

Keep reading...Show less
Cardiex Limited (ASX:CDX)

Cardiex Limited


Keep reading...Show less

Bausch Health and Salix in Collaboration with Health Organizations Recognize the Second Annual Opioid-Induced Constipation Awareness Day

Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC) and its gastroenterology (GI) business, Salix Pharmaceuticals ("Salix"), alongside the U.S. Pain Foundation (USPF), the International Foundation for Gastrointestinal Disorders (IFFGD), and the American Chronic Pain Association (ACPA) have united to recognize today, Thursday, December 5, as the second annual Opioid-Induced Constipation (OIC) Awareness Day. This important day is dedicated to bringing awareness to a commonly-overlooked side effect of opioids. By raising awareness and fostering open conversations, OIC Awareness Day seeks to reduce the stigma surrounding this condition and offer support to the many patients impacted by OIC

"As an organization dedicated to supporting individuals living with pain conditions, we're proud to participate in this year's OIC Awareness Day," said Kathy Sapp, CEO of ACPA. "By increasing awareness and improving communication between healthcare providers, patients, and caregivers, we can make a meaningful difference for those affected by this commonly occurring condition."

News Provided by ACCESSWIRE via QuoteMedia

Keep reading...Show less

Global Medical Service Robotics Market Project to Exceed $20 Billion in 2024 with Additional Growth Expected

FN Media Group News Commentary - Innovations in robotics technology, including artificial intelligence machine learning, and sensor technology, are enhancing the capabilities of medical robots. These advancements enable more precise surgical procedures, improved rehabilitation processes, and efficient hospital logistics, thus attracting more healthcare facilities to adopt robotic solutions. The market is characterized by a moderate level of merger and acquisition (M&A) activity by the leading players. This is due to several factors, including the desire to expand the business to cater to the growing demand for medical service robots. A report from Grand View Research said that the global medical service robots market size was estimated at USD 20.59 billion in 2024 and is projected to grow at a CAGR of 16.5% from 2025 to 2030. It said: "The growth can be attributed to the introduction of technologically advanced robotic equipment in the healthcare sector and the rise in per capita healthcare spending. Continuous advancements in technology, such as robotic catheter control systems (CCS), data recorders, data analytics, remote navigation, motion sensors, 3D-Imaging, and HD surgical microscopic cameras, are projected to drive industry growth. Furthermore, the introduction of swarm robotics is opening new opportunities for industry. It is a new approach to coordinating multi-robotic systems through swarm intelligence." Active Tech Companies in the markets today include Jeffs' Brands Ltd (NASDAQ: JFBR), Serve Robotics Inc. (NASDAQ: SERV), Symbotic Inc. (NASDAQ: SYM), Microbot Medical Inc. (NASDAQ: MBOT), Medtronic plc (NYSE: MDT).

News Provided by GlobeNewswire via QuoteMedia

Keep reading...Show less

Latest Press Releases

Related News

×